For press inquiries, please send an e-mail to media@mappbio.com.
The following links provide useful information about MappBio and Ebola Antibody Treatment:
MB66 FAQ – MB66 is a multipurpose prevention technology intended to block sexual transmission of genital herpes and HIV. It is currently being evaluated for safety and efficacy by a consortium of investigators.